Ruben Kuzniecky

Last updated

Ruben Kuzniecky
Rk02.jpg
Ruben Kuzniecky, 2009
Born (1957-08-18) August 18, 1957 (age 66)
Education University of Buenos Aires, Montreal Neurological Institute
RelativesWife: Yvonne Kuzniecky (1983–present)
Medical career
InstitutionsVice Chair academic affairs and Director of Northwell Health Neurology Research, Professor of Neurology

Ruben Kuzniecky is a neurologist scientist who is Vice-chair academic affairs and professor of neurology at Northwell Health specializing in the field of epilepsy, epilepsy surgery and neuro-imaging.

Contents

He was one of the first to recognize and prove that mesial temporal sclerosis, a common cause for difficulty in controlling temporal lobe epilepsy, can be identified with MRI scans. He also described the Kuzniecky Syndrome in 1991, also known as perisylvian polymicrogyria. The syndrome is characterized by seizures, cognitive abnormalities, and a peculiar inability to use the mouth and tongue muscles. This syndrome is recognized by as a specific malformation of the brain.[ citation needed ]

Early life

Kuzniecky was born in Panama City, Republic of Panama, the son of Betzalel and Sara Kuzniecky. His parents were educators and founded and directed schools in Panama such as the Instituto Alberto Einstein and later on the Instituto Pedagogico. Kuzniecky attended the Instituto Pedagogico in Panama and graduated from the Instituto Wolfshon in Buenos Aires, Argentina. He excelled in high school as an athlete, finishing in 4th place in the 100 and 200 meter dash at the age of 16 in the Panama national school track and field championship. He entered the Universidad de Buenos Aires medical school in 1975 and graduated in 1981.[ citation needed ]

Career

After finishing medical school, Kuzniecky did a six-month stint as a research fellow at the Institute of Medical Research of the University of Buenos Aires. He then returned to Panama where he completed a one-year internship at the CSS hospital in Panama City and then went into his second year of internship in the countryside. In 1983 he was accepted to the Montreal neurological Institute, McGill University, for a neurology residency. He went into an epilepsy/EEG fellowship at the Montreal Neurological Institute under Drs. Pierre Gloor and Fred Andermann, which he completed in 1988. That year he was appointed as Assistant Professor of Neurology at the University of Alabama Birmingham, where he began his academic career. In 1992 he became Director of the UAB epilepsy center, a post he held until 2003. In 1997-1998 he was appointed as visiting professor at the Department of Physics at the University College of London, where he did magnetic resonance imaging research.

In 1997, at the age of 40, he became full professor of Neurology and Neurosurgery at UAB and served as interim chair of the Department of Neurology in 2002. In 2003 he was appointed as Professor and Co-director of NYU Epilepsy Center at NYU School of Medicine, New York and in August 2017 he was appointed as vice-chair, Academic affairs and director clinical research, Department of Neurology at Northwell health. His research is centered on the use of Magnetic Resonance Imaging and its applications to epilepsy and on unraveling the major developmental brain malformations in epilepsy. He was the first to recognize and prove that mesial temporal sclerosis, a common cause for difficult epilepsy, can be identified with MRI. [1]

In the area of brain malformations, he is the co-author of the widely recognized classification scheme. [2] He has authored over 350 chapters and journal articles on a number of topics related to epilepsy. He has written two books on MRI applications in epilepsy, and more recently two patient oriented books, Epilepsy 101:The Ultimate Guide for Patients and Families. [3] and Epilepsy surgery: a guide for patients. [4]

In 2007, Kuzniecky was co-awarded a major grant from the National Institutes of Health to organize the Epilepsy Phenome/Genome Project. [5]

Kuzniecky described the Kuzniecky Syndrome in 1991, also known as perisylvian polymicrogyria. [6] The syndrome is characterized by seizures, cognitive abnormalities, and a peculiar inability to use the mouth and tongue muscles. This syndrome is recognized by as a specific malformation of the brain. [7]

MRI showing the abnormal infolding of the perisylvian region typical of this syndrome. The abnormality is due to polymicrogyria. KuznieckySyndrome.png
MRI showing the abnormal infolding of the perisylvian region typical of this syndrome. The abnormality is due to polymicrogyria.

Additional research projects include the development of a watch sensor to detect convulsive seizures. [8] Kuzniecky continues to work on the Analysis of the Epilepsy Genome Phenome project through the EPi4K Genomic Discovery team. In addition, Kuzniecky, in conjunction with Dr. Daniel Lowenstein and Dr. Jacqueline French, launched the Human Epilepsy Project (HEP). [9] This project, involving 30 sites, aims to recruit 500 patients with new onset epilepsy and follow them up for seven years. In 2018, the HEP 2 project funded through the epilepsy foundation of America is starting to recruit patients at Northwell health. More recently, Dr. Kuzniecky launched a study of cardiac function in epilepsy using the Linq cardiac monitor with the aim of monitoring cardiac rhythm long-term.

In the past years, Kuzniecky began a program to help children from Panama with severe epilepsy to have access to surgical treatment by collaborating with Panama neurologists and bringing a US epilepsy team member to Panama's children's hospital. Since 2013, in conjunction with Dr. Howard Weiner from Texas Children's Hospital and others, the team has operated on many children with severe epilepsy. [10] The program has been supported by Panama's first lady office of social programs. In 2016 he founded the non-profit foundation LUCES PANAMA that provides free anti-seizure medications to poor children with epilepsy in Panama. [11]

He has been recognized for his efforts in the "Best Doctors in America" in 1995, 1998, and 2002–2017, and by the New Yorker since 2004 as one of the best doctors in the New York Metro area. [12] [13] In 2013, Kuzniecky was presented with the American Registry's 'Most Compassionate Doctor' Award. He has been listed among New York Magazine's Best Doctors and Castle Connolly America's Top Doctors for several consecutive years. In December 2020 Kuzniecky was awarded the 2020 American Epilepsy Society clinical science research award for his seminal contributions to the treatment of epilepsy. [14]

Kuzniecky attends to patients with epilepsy and complex neurologic disorders at the Lennox-Hill hospital Northwell Health. He has been recognized as a leading expert in epilepsy, epilepsy surgery, epilepsy imaging and malformations of the brain and epilepsy and is widely respected in the medical community. [15]

Publications

Patents

Personal life

After his move to NYU, Kuzniecky took residency in New Jersey where he lives with his wife Yvonne. His three children live in New York City.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Arteriovenous malformation</span> Vascular anomaly

An arteriovenous malformation (AVM) is an abnormal connection between arteries and veins, bypassing the capillary system. Usually congenital, this vascular anomaly is widely known because of its occurrence in the central nervous system, but can appear anywhere in the body. The symptoms of AVMs can range from none at all to intense pain or bleeding, and they can lead to other serious medical problems.

<span class="mw-page-title-main">Megalencephaly</span> Medical condition

Megalencephaly is a growth development disorder in which the brain is abnormally large. It is characterized by a brain with an average weight that is 2.5 standard deviations above the mean of the general population. Approximately 1 out of 50 children (2%) are said to have the characteristics of megalencephaly in the general population.

Aicardi syndrome is a rare genetic malformation syndrome characterized by the partial or complete absence of a key structure in the brain called the corpus callosum, the presence of retinal lacunes, and epileptic seizures in the form of infantile spasms. Other malformations of the brain and skeleton may also occur. The syndrome includes intellectual disability that is usually severe or moderate. So far, the syndrome has only been diagnosed in girls and in boys with two X chromosomes.

<span class="mw-page-title-main">Polymicrogyria</span> Medical condition

Polymicrogyria (PMG) is a condition that affects the development of the human brain by multiple small gyri (microgyri) creating excessive folding of the brain leading to an abnormally thick cortex. This abnormality can affect either one region of the brain or multiple regions.

Bilateral frontoparietal polymicrogyria is a genetic disorder with autosomal recessive inheritance that causes a cortical malformation. Our brain has folds in the cortex to increase surface area called gyri and patients with polymicrogyria have an increase number of folds and smaller folds than usual. Polymicrogyria is defined as a cerebral malformation of cortical development in which the normal gyral pattern of the surface of the brain is replaced by an excessive number of small, fused gyri separated by shallow sulci and abnormal cortical lamination. From ongoing research, mutation in GPR56, a member of the adhesion G protein-coupled receptor (GPCR) family, results in BFPP. These mutations are located in different regions of the protein without any evidence of a relationship between the position of the mutation and phenotypic severity. It is also found that GPR56 plays a role in cortical pattering.

Corpus callosotomy is a palliative surgical procedure for the treatment of medically refractory epilepsy. In this procedure the corpus callosum is cut through, in an effort to limit the spread of epileptic activity between the two halves of the brain.

<span class="mw-page-title-main">Lennox–Gastaut syndrome</span> Rare form of childhood-onset epilepsy

Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy syndrome. It is characterized by multiple and concurrent seizure types including tonic seizure, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG), which are very abnormal. Typically, it presents in children aged 3–5 years and most of the time persists into adulthood with slight changes in the electroclinical phenotype. It has been associated with perinatal injuries, congenital infections, brain malformations, brain tumors, genetic disorders such as tuberous sclerosis and numerous gene mutations. Sometimes LGS is observed after infantile epileptic spasm syndrome. The prognosis for LGS is marked by a 5% mortality in childhood and persistent seizures into adulthood.

<span class="mw-page-title-main">Sturge–Weber syndrome</span> Medical condition

Sturge–Weber syndrome, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, intellectual disability, and ipsilateral leptomeningeal angioma. Sturge–Weber syndrome can be classified into three different types. Type 1 includes facial and leptomeningeal angiomas as well as the possibility of glaucoma or choroidal lesions. Normally, only one side of the brain is affected. This type is the most common. Type 2 involvement includes a facial angioma with a possibility of glaucoma developing. There is no evidence of brain involvement. Symptoms can show at any time beyond the initial diagnosis of the facial angioma. The symptoms can include glaucoma, cerebral blood flow abnormalities and headaches. More research is needed on this type of Sturge–Weber syndrome. Type 3 has leptomeningeal angioma involvement exclusively. The facial angioma is absent and glaucoma rarely occurs. This type is only diagnosed via brain scan.

<span class="mw-page-title-main">Temporal lobe epilepsy</span> Chronic focal seizure disorder

In the field of neurology, temporal lobe epilepsy is an enduring brain disorder that causes unprovoked seizures from the temporal lobe. Temporal lobe epilepsy is the most common type of focal onset epilepsy among adults. Seizure symptoms and behavior distinguish seizures arising from the medial temporal lobe from seizures arising from the lateral (neocortical) temporal lobe. Memory and psychiatric comorbidities may occur. Diagnosis relies on electroencephalographic (EEG) and neuroimaging studies. Anticonvulsant medications, epilepsy surgery and dietary treatments may improve seizure control.

Epileptic spasms is an uncommon-to-rare epileptic disorder in infants, children and adults. One of the other names of the disorder, West syndrome, is in memory of the English physician, William James West (1793–1848), who first described it in an article published in The Lancet in 1841. The original case actually described his own son, James Edwin West (1840–1860). Other names for it are "generalized flexion epilepsy", "infantile epileptic encephalopathy", "infantile myoclonic encephalopathy", "jackknife convulsions", "massive myoclonia" and "Salaam spasms". The term "infantile spasms" can be used to describe the specific seizure manifestation in the syndrome, but is also used as a synonym for the syndrome itself. West syndrome in modern usage is the triad of infantile spasms, a pathognomonic EEG pattern, and developmental regression – although the international definition requires only two out of these three elements.

<span class="mw-page-title-main">Frederick Andermann</span> Canadian neurologist and epileptologist (1930–2019)

Frederick Andermann was a Canadian neurologist and epileptologist.

Abdominal epilepsy is a rare condition most frequently found in children, consisting of gastrointestinal disturbances caused by epileptiform seizure activity. Though a few cases of it have been reported in adults too. It has been described as a type of temporal lobe epilepsy. Responsiveness to anticonvulsants can aid in the diagnosis. Distinguishing features of abdominal epilepsy include (1) Abnormal laboratory, radiographic, and endoscopic findings revealing paroxysmal GI manifestations of unknown origin (2) CNS symptoms (3) Abnormal EEG. Most published medical literature dealing with abdominal epilepsy is in the form of individual case reports. A 2005 review article found a total of 36 cases described in the medical literature.

<span class="mw-page-title-main">Macrocephaly-capillary malformation</span> Medical condition

Macrocephaly-capillary malformation (M-CM) is a multiple malformation syndrome causing abnormal body and head overgrowth and cutaneous, vascular, neurologic, and limb abnormalities. Though not every patient has all features, commonly found signs include macrocephaly, congenital macrosomia, extensive cutaneous capillary malformation, body asymmetry, polydactyly or syndactyly of the hands and feet, lax joints, doughy skin, variable developmental delay and other neurologic problems such as seizures and low muscle tone.

Vertiginous epilepsy is infrequently the first symptom of a seizure, characterized by a feeling of vertigo. When it occurs, there is a sensation of rotation or movement that lasts for a few seconds before full seizure activity. While the specific causes of this disease are speculative there are several methods for diagnosis, the most important being the patient's recall of episodes. Most times, those diagnosed with vertiginous seizures are left to self-manage their symptoms or are able to use anti-epileptic medication to dampen the severity of their symptoms.

Orrin Devinsky is an American neurologist who is the Director of the NYU Comprehensive Epilepsy Center and the Saint Barnabas Institute of Neurology and Neurosurgery (INN). He is also a professor of Neurology, Neurosurgery, and Psychiatry at NYU Langone School of Medicine. Devinsky specializes in epilepsy and behavioral neurology.

PHACE syndrome is a medical condition involving the uncommon association between large infantile hemangiomas, usually of the face, and birth defects of the brain, heart, eyes, skin and/or arteries. PHACE is an acronym that stands for the medical names of the parts of the body it often impacts:

<span class="mw-page-title-main">Ulegyria</span> Type of cortical scarring deep in the sulci

Ulegyria is a diagnosis used to describe a specific type of cortical scarring in the deep regions of the sulcus that leads to distortion of the gyri. Ulegyria is identified by its characteristic "mushroom-shaped" gyri, in which scarring causes shrinkage and atrophy in the deep sulcal regions while the surface gyri are spared. This condition is most often caused by hypoxic-ischemic brain injury in the perinatal period. The effects of ulegyria can range in severity, although it is most commonly associated with cerebral palsy, mental retardation and epilepsy. N.C. Bresler was the first to view ulegyria in 1899 and described this abnormal morphology in the brain as “mushroom-gyri." Although ulegyria was first identified in 1899, there is still limited information known or reported about the condition.

Sunil Pradhan is an Indian neurologist, medical researcher and writer, known for the invention of two electrophysiological techniques. He has also described five medical signs, of which one related to Duchenne muscular dystrophy is known as Pradhan Sign, and the others associated with facioscapulohumeral muscular dystrophy (FSHD) and similar neuro diseases. The Government of India awarded him the Padma Shri, the fourth highest civilian award, in 2014 for his contributions to the field of neuroscience.

<span class="mw-page-title-main">Congenital bilateral perisylvian syndrome</span> Medical condition

Congenital bilateral perisylvian syndrome (CBPS) is a rare neurological disease characterized by paralysis of certain facial muscles and epileptic seizures.

Victoria L. Morgan is an American biomedical engineer who is a professor of neurology and radiology at Vanderbilt University. She makes use of functional magnetic resonance imaging to understand neural activation and function. Her research looks to quantify and understand the impact of epilepsy in the brain.

References

  1. Kuzniecky, Ruben I. (2005). "Neuroimaging of Epilepsy: Therapeutic Implications". Neurotherapeutics. 2: 384–393. doi:10.1602/neurorx.2.2.384.
  2. Barkovich, A. J.; Kuzniecky, R. I.; Jackson, G. D.; Guerrini, R.; Dobyns, W. B. (26 December 2001). "Classification system for malformations of cortical development: Update 2001". Neurology. 57 (12): 2168–2178. doi:10.1212/WNL.57.12.2168.
  3. Epilepsy 101: the ultimate guide for patients and families. Medicus Press. 2009. ISBN   9780978772734. OCLC   715620081.
  4. Epilepsy Surgery: A Guide for Patients and Families. Medicus Press. 12 August 2016.
  5. "The Epilepsy Phenome/Genome Project: A New Initiative to Understand the Genetic Causes of Epilepsy". NYU Lagone Medical Center. Archived from the original on 30 January 2009.
  6. Kuzniecky, Ruben; Andermann, Frederick; Guerrini, Renzo (March 1994). "The epileptic spectrum in the congenital bilateral perisylvian syndrome". Neurology. 44. doi:10.1212/WNL.44.3_Part_1.379.
  7. "Pachygyria With Mental Retardation, Seizures, And Arachnoid Cysts". The National Center for Biotechnology. Retrieved 22 May 2024.
  8. "Product". BioLert. Archived from the original on 8 October 2016.
  9. "Research Team". Human Epilepsy Project. Retrieved 22 May 2024.
  10. "Niña operada de epilepsia recibe visita de la Primera Dama". Gobierno Nacional República de Panamá (in Spanish). 13 August 2013. Archived from the original on 18 September 2013.
  11. "Home". Fundación Luces Panamá. Archived from the original on 2 June 2022.
  12. ""America's Best Doctors" Lists 167 UAB Physicians". University of Alabama. 17 January 2002. Archived from the original on 13 June 2010.
  13. "Dr. Ruben Zuzniecky". Castle Connolly Top Doctors. Archived from the original on 22 August 2017.
  14. "Clinical researcher recognized by the American Epilepsy Society". The Island Now. 14 February 2024. Retrieved 22 May 2024.
  15. "Dr. Ruben I. Kuzniecky, MD". vitals.com. Retrieved 22 May 2024.